Intensity Therapeutics INTS
NASDAQ INTS
$3.28 -0.01 (-0.30%)
As of: Oct 20, 2026 · 3:59 PM EDT

Intensity Therapeutics (INTS) Invested Capital (2022)

Updated

Intensity Therapeutics (INTS) posted Invested Capital of -$10.75 million for Q4 2022.

Analysis

Intensity Therapeutics (INTS) Invested Capital (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,137.84 Bn 1,106.42 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 618.03 Bn 536.55 Bn 17.26 Bn 134.01 Bn
3 AbbVie 507.69 Bn 480.80 Bn 12.70 Bn 64.89 Bn
4 Merck 366.91 Bn 321.28 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 298.54 Bn 262.53 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 263.16 Bn 236.84 Bn 12.86 Bn 82.72 Bn
7 Amgen 236.31 Bn 191.71 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 192.91 Bn 167.11 Bn 6.22 Bn 38.08 Bn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn 148.69 Bn
10 Intensity Therapeutics 9.96 Mn -28.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -10.75 Mn
API Access

Intensity Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=INTS&period=max&api_key=YOUR_API_KEY